Skip to content
Screener

Investing Cash Flow at other companies

Eli Lilly logo
Eli LillyLLY
-$15.4B-739%
LON
LeonaBio, Inc.LONA
-$15.54M-111%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
-$17.98M-180%
Opko Health logo
Opko HealthOPK
$15.54M
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$50.69M+272%
IDEAYA Biosciences, Inc. logo
IDEAYA Biosciences, Inc.IDYA
$118.95M+49.0%

Other financials

Income statement

See full
Operating income-$58.0M-66.3%
Net income-$53.1M-74.7%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$52.5M+3.8%
Total debt$956.0K-16.7%
Total equity$480.5M+25.3%
Total assets$530.6M+29.5%

Cash flow

See full
Operating cash flow-$46.0M-4.6%
CapEx-
Free cash flow-$34.5M-27.8%

Valuation

See full
Market cap$1.03B+202%
Enterprise value$979.11M+238%

Returns & leverage

See full
Return on equity-42.9%+1.3pp
Debt / equity0.0×
Current ratio10.9×-4.3×

Where this comes from

Reported directly by Olema Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.

The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 7:10 AM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-218156
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Cash flows from investing activities:
Maturities of marketable securities74,47097,772
Purchases of marketable securities(69,941)(142,855)
Net cash provided by (used in) investing activities4,529(45,083)
Cash flows from financing activities:
Issuance of shares under at-the-market offering, net of issuance costs of $2541,918
Issuance costs for shares issued under November 2025 follow-on offering(237)
Issuance costs for shares issued under private placement(14)

Item 1. Financial Statements.

FAQ

What is Olema Pharmaceuticals, Inc.'s investing cash flow?
Olema Pharmaceuticals, Inc. (OLMA) reported investing cash flow of $4.53M in Q1 2026.
How has Olema Pharmaceuticals, Inc.'s investing cash flow changed year-over-year?
Olema Pharmaceuticals, Inc.'s investing cash flow increased by 110.0% year-over-year, from -$45.08M to $4.53M.
What is the long-term trend for Olema Pharmaceuticals, Inc.'s investing cash flow?
Over 2 years (2022 to 2024), Olema Pharmaceuticals, Inc.'s investing cash flow has grown at a 1.1% compound annual growth rate (CAGR), from $91.48M to -$93.53M.
What does investing cash flow mean?
Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.

Ask your AI about Olema Pharmaceuticals, Inc.'s investing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude